Tor K. Larsen
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.
Journal: Psychiatry research
Published: December 23, 2025
Reply to a Letter to the Editors From Dr de Souza and colleagues: "Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum: A Quest for Clarity".
Journal: Journal of clinical psychopharmacology
Published: December 15, 2023
Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis.
Journal: Psychological medicine
Published: May 05, 2023
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro).
Journal: Journal of clinical psychopharmacology
Published: April 21, 2023
Remission in schizophrenia spectrum disorders: A randomized trial of amisulpride, aripiprazole and olanzapine.
Journal: Schizophrenia research
Published: January 12, 2023
Association between early suicidal trajectories in first-episode psychosis and 10-year follow-up: TIPS registry-linked study.
Journal: The lancet. Psychiatry
Published: December 06, 2022
Psychiatric patients' attitudes towards being hospitalized: a national multicentre study in Norway.
Journal: BMC psychiatry
Published: May 31, 2022
The association between cytokines and psychomotor speed in a spectrum of psychotic disorders: A longitudinal study.
Journal: Brain, behavior, & immunity - health
Published: October 20, 2021
Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness.
Journal: World journal of psychiatry
Published: September 22, 2021
Impact of childhood trauma on antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, semi-randomized trial.
Journal: Schizophrenia research
Published: September 16, 2021
Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis.
Journal: Schizophrenia research
Published: April 05, 2021
Last Updated: 09/26/2026